What's New at the NGVB

August 1, 2016

The spotlight has shined brightly on the gene therapy field recently and the NGVB is proud to be a part of it. Our clinical trial testing support for academic investigators utilizing retrovirus and lentivirus vectors has ensured FDA compliance while easing budget constraints in this challenging funding climate. Register your clinical trial with the NGVB today and put us to work for you!

We have observed a heightened interest in insertional site/clonal analysis. In response to this, we have developed a testing pipeline that will utilize nrLAM PCR and next generation sequence technology (see http://www.ncbi.nlm.nih.gov/pubmed/20671722). We now offer nrLAM PCR as a service.

The pharmtox database now includes non-GLP "Proof of Concept" studies submitted to the FDA in support of IND submission.

As always, if you have any suggestions for testing needs or storage services beyond what are currently offered, let us know.

Lorraine Matheson
NGVB Biorepository Manager
Please enable JavaScript in your browser to see the e-mail address.
Support Gene Therapy Research!
Contribute your Reagent or Pharm/Tox Study to the NGVB. Contact The NGVB Coordinating Center for details.